CoChat

Immunoreactive Gastric Inhibitory Polypeptide*

KRARUP, THURE · 1988 · Endocrine Reviews
Cited by 96

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Abstract

IN 1906 extracts of mucosa from the upper small intestine from pigs were tested as a treatment of diabetes in the hope that “the internal secretion of the pancreas might be stimulated and initiated by the substance of the nature of a hormone yielded by the duodenal mucous membrane” (1). La Barre (2) introduced the name incretin for an unidentified substance that was thought to exert this effect. With the advent of insulin RIAs in the early 1960s (3), it was shown that insulin levels in the blood after ingestion of glucose were elevated out of proportion to the concentration of blood glucose when compared with the response to glucose given iv (4, 5). It was suggested that the potentiation of insulin secretion after oral glucose was mediated by a humoral substance which was released from the gut during glucose absorption and which stimulated insulin secretion (4, 5). Some years later a polypeptide was found (6, 7), which, due to its inhibitory effect on gastric acid secretion in dogs (8), was named gastric inhibitory polypeptide (GIP) (6, 7). Intravenous infusion of natural porcine GIP significantly enhanced serum immunoreactive insulin (IRI) and improved glucose tolerance after iv glucose in man (9). Later studies showed that GIP was insulinotropic only at glucose concentrations above 5.5–6.0 mmol/liter (10–12), and it was suggested that GIP should be renamed glucose-dependent insulinotropic polypeptide (13). There is, however, no general agreement to this new designation so the original name will be used throughout this review. Today GIP is considered to be the most important incretin factor (14–16), whereas the inhibitory effect of GIP on gastric acid secretion in normal subjects has been questioned (15).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/edrv-9-1-122

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Cited by

See all 96

Metadata

Authors
KRARUP, T.
Venue
Endocrine Reviews
Published
1988-02
Volume
9
Issue
1
Pages
122-134
ISSN
  • 0163-769X (ISSN-L)
  • 1945-7189
OpenAlex
W2010658627
Cited by
96
References
13
FWCI
3.09
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Immunoreactive Gastric Inhibitory Polypeptide*. https://app.cochat.ai/papers/10.1210/edrv-9-1-122
The paper
KRARUP, T. (1988). Immunoreactive Gastric Inhibitory Polypeptide*. Endocrine Reviews. https://doi.org/10.1210/edrv-9-1-122

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.